翁志銘(Weng, Chih-Ming) 助理教授

Email
m109090013@tmu.edu.tw
現   職
呼吸治療學系 助理教授

學經歷

學 歷

畢業學校與學位[修業時間]
臺北醫學大學醫學科學研究所 博士
2006/08~2013/06
臺北醫學大學生物醫學技術研究所 碩士
2001/09~2003/06
臺北醫學大學醫學檢驗暨生物技術學系 學士
1997/09~2001/06

本校學術經歷

任職單位與職稱[起迄時間]
呼吸治療學系助理教授
2019/01/11~

本校兼職教學行政經歷

服務單位與職稱[起迄時間]
無資料!

其它經歷

任職單位與職稱[起迄時間]
臺北醫學大學醫學系博士後研究員
2018/04~2019/01
長庚大學博士後研究員
2015/10~2018/03
臺北醫學大學醫學科學研究所博士後研究員
2015/01~2015/08
長庚醫療財團法人呼吸胸腔科博士後研究員
2013/08~2015/01

專長與研究領域

學門領域
藥理及毒理
Pharmacology and Toxicology
胸腔內科
Chest
學術專長
細胞訊息傳遞
細胞訊息傳遞
發炎反應
發炎反應
氣喘
氣喘

論文著作

清冊下載


1. 2024 Wang CM,Wu WC,Lee MJ,Chen MC,Chou CL,Lin CY, Chung KF, Kuo HO. Influence of Staphylococcal enterotoxin-specific IgE sensitization on therapeutic efficacy of omalizumab therapy in severe asthma . Respirology .2024 ;(29):252-255

2. 2023 Yang FM,Hu MC,Weng CM,Chuang HC,Lan YT,Su BH, Heo KS, Kuo HP. Loss of PP4 contributes to diesel exhaust particles-induced epithelial barrier integrity disruption and alarmins release . Allergy .2023

3. 2023 Hua HS,Wen HC,Lee HS,Weng CM,Fara Silvia Yuliani,Kuo HP, Chen BC, Lin CH. Endothelin-1 induces connective tissue growth factor expression in human lung fibroblasts by disrupting HDAC2/Sin3A/MeCP2 corepressor complex . J Biomed Sci. .2023

4. 2023 Weng CM,Lee MJ,Chao W,Lin YR,Chou CJ,Chen MC, Chou CL, Tsai IL, Lin CH, Chung KF, Kuo HP. Airway epithelium IgE-FcεRI cross-link induces epithelial barrier disruption in severe T2-high asthma . Mucosal Immunology .2023

5. 2022 Lee MJ,Weng CM,Chao W,Fang YF,Chung FT,Lin CH, Kuo HP. Platelet Activation in High D-Dimer Plasma Plays a Role in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Mutant Lung Adenocarcinoma . Frontiers in Oncology .2022

6. 2022 Chen MC,Lai SL,Chien KL,Teng ST,Lin YR,Chao W, Lee MJ, Wei PL, Huang YH, Kuo HP, Weng CM, Chou CL. pcMSC Modulates Immune Dysregulation in Patients With COVID-19-Induced Refractory Acute Lung Injury . Frontiers in Immunology .2022

7. 2022 Wang CH,Lo CY,Huang HY,Wang TY,Weng CM,Chen CJ, Huang YC, Chung FT, Lin CW, Chung KF, Kuo HP. Oxygen Desaturation Is Associated With Fibrocyte Activation via Epidermal Growth Factor Receptor/Hypoxia-Inducible Factor-1α Axis in Chronic Obstructive Pulmonary Disease . Frontiers in Immunology .2022

8. 2021 Wang CH,Weng CM,Huang TT,Lee MJ,Lo CY,Chen MC, Chou CL, Kuo HP. Anti-IgE therapy inhibits chemotaxis, proliferation and transformation of circulating fibrocytes in patients with severe allergic asthma . Respirology .2021 ;(26):842-850

9. 2021 Hua HS,Wen HC,Weng CM,Lee HS,Chen BC,Lin CH. Histone deacetylase 7 mediates endothelin-1-induced connective tissue growth factor expression in human lung fibroblasts through p300 and activator protein-1 activation . J Biomed Sci .2021

10. 2019 Yu‐Chen Huang,Chih‐Ming Weng,Meng‐Jung Lee,Shu‐Min Lin,Chun‐Hua Wang,Han‐Pin Kuo. Endotypes of severe allergic asthma patients who clinically benefit from anti-IgE therapy . Clinical & experimental allrergy .2019 ;(49):44-53

11. 2018 C.‐M. Weng,C.-H. Wang,M.‐J. Lee,J.‐R. He,H.‐Y. Huang,M.‐W. Chao, 「K. F. Chung,」「 H.‐P. Kuo」. Aryl hydrocarbon receptor activation by diesel exhaust particles mediates epithelium-derived cytokines expression in severe allergic asthma . Allergy .2018 ;(73):2192-2204

12. 2018 C.‐M. Weng,M.‐J. Lee,J.‐R. He,M.‐W. Chao,C.‐H.Wang, H.‐P. Kuo. Diesel exhaust particles up-regulate interleukin-17A expression via ROS/NF-κB in airway epithelium . Biochemical Pharmacology .2018 ;(151):1-8

13. 2014 C.‐M. Weng,C.-C. Yu,M.-L. Kuo,B.-C. Chen,C.-H. Lin. Endothelin-1 induces connective tissue growth factor expression in human lung fibroblasts by ETAR-dependent JNK/AP-1 pathway . Biochemical pharmacology .2014 ;(88):402-411


1. 2023 Wang CM,Lee MJ,Lin YR,Chen MC,Wu WC,Kuo HP. Fibrocytes Induced Airway Epithelial Dysfunction in Severe T2-high Asthma by Producing T2 Cytokines . ERS international congress 2023 .2023

2. 2022 Chen MC,Lai SL,Chien KL,Teng ST,Lin YR,Chao W, Lee MJ, Wei PL, Huang YH, Kuo HP, Weng CM, Chou CL. Impact of Placenta-Derived Mesenchymal Stem Cells on Patients withSevere Lung Injury Caused by COVID-19 Pneumonia: Clinical, SerumCytokine and Immune Aspect . Am J Respir Crit Care Med .2022

研究計畫

計畫名稱
113 TSLP/IL-7Ralpha在嚴重T2氣喘中調控上皮屏障崩壞之角色探討(2/3)
補助單位
國家科學及技術委員會

計畫名稱
112 TSLP/IL-7Ralpha在嚴重T2氣喘中調控上皮屏障崩壞之角色探討(1/3)
補助單位
國家科學及技術委員會

計畫名稱
111 上調表現之FceRI造成嚴重過敏性氣喘中上皮組織不穩定性以及上皮免疫微環境不平衡
補助單位
國家科學及技術委員會

計畫名稱
110 柴油引擎廢氣粒子媒介嚴重氣喘氣道上皮層之肥大細胞活化與細胞激素釋放
補助單位
科技部

計畫名稱
109 嚴重氣喘患者呼吸道上皮細胞之IgE媒介警告素生成過程,其High affinity IgE receptor及E-cadherin之角色與機轉(2/2)
補助單位
科技部

計畫名稱
108 新聘教師研究補助
補助單位
臺北醫學大學

計畫名稱
108 嚴重氣喘患者呼吸道上皮細胞之IgE媒介警告素生成過程,其High affinity IgE receptor及E-cadherin之角色與機轉(1/2)
補助單位
科技部